Sulindac and Injection site warmth - a phase IV clinical study of FDA data

Summary:

Injection site warmth is reported as a side effect among people who take Sulindac (sulindac), especially for people who are female, 60+ old, also take Humira, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Injection site warmth when taking Sulindac. It is created by eHealthMe based on reports of 3,687 people who have side effects when taking Sulindac from the FDA, and is updated regularly.

What is Sulindac?

Sulindac has active ingredients of sulindac. It is often used in rheumatoid arthritis. eHealthMe is studying from 3,824 Sulindac users. Check the latest studies of Sulindac.

What is Injection site warmth?

Injection site warmth is found to be associated with 525 drugs and 700 conditions by eHealthMe. Check the latest studies of Injection site warmth.

On Aug, 01, 2026

3,687 people reported to have side effects when taking Sulindac.
Among them, 11 people (0.3%) have Injection site warmth.

Could Sulindac cause Injection site warmth?

Among these 11 people:

What is the gender of people who have Injection site warmth when taking Sulindac? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Injection site warmth when taking Sulindac? *

What are other drugs people take besides Sulindac? *

What are other side effects people have besides Injection site warmth? *

Injection Site Erythema (redness at injection site): 10 people, 90.91%
Injection Site Pruritus (severe itching at injection site): 8 people, 72.73%
Injection Site Reaction: 4 people, 36.36%
Injection Site Swelling: 4 people, 36.36%
Injection Site Nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site): 3 people, 27.27%
Feeling Abnormal: 3 people, 27.27%
Chest Pain: 3 people, 27.27%
Pleural Effusion (water on the lungs): 2 people, 18.18%
Drug Ineffective: 2 people, 18.18%
Injection Site Rash: 2 people, 18.18%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 27.27%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 9.09%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sulindac and have Injection site warmth?

- Check whether Injection site warmth is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sulindac:

Sulindac (3,824 reports)

Browse all side effects of Sulindac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site warmth:

Injection site warmth (525 drugs)

Browse all the conditions that are associated with Injection site warmth:

Injection site warmth (700 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulindac (the active ingredients of Sulindac) and Sulindac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.